| Primary |
| Hypogammaglobulinaemia |
14.5% |
| Immunodeficiency Common Variable |
14.5% |
| Chronic Lymphocytic Leukaemia |
11.3% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
6.5% |
| Non-hodgkin's Lymphoma |
6.5% |
| Demyelinating Polyneuropathy |
4.8% |
| Immunodeficiency |
4.8% |
| Lymphocytic Leukaemia |
4.8% |
| Blood Immunoglobulin G Decreased |
3.2% |
| Guillain-barre Syndrome |
3.2% |
| Hypoglobulinaemia |
3.2% |
| Multifocal Motor Neuropathy |
3.2% |
| Myasthenia Gravis |
3.2% |
| Neuropathy Peripheral |
3.2% |
| Product Used For Unknown Indication |
3.2% |
| Secondary Immunodeficiency |
3.2% |
| Anaemia Haemolytic Autoimmune |
1.6% |
| Autoimmune Thrombocytopenia |
1.6% |
| Chronic Sinusitis |
1.6% |
| Congenital Hypogammaglobulinaemia |
1.6% |
|
| Infusion Related Reaction |
12.5% |
| Wheezing |
8.3% |
| Back Pain |
6.3% |
| Dyspnoea |
6.3% |
| Headache |
6.3% |
| Tremor |
6.3% |
| Vomiting |
6.3% |
| Blood Pressure Increased |
4.2% |
| Chest Pain |
4.2% |
| Chills |
4.2% |
| Dysgeusia |
4.2% |
| Hepatitis B |
4.2% |
| Meningitis Aseptic |
4.2% |
| Pyrexia |
4.2% |
| Tachycardia |
4.2% |
| Thrombocytopenia |
4.2% |
| Urticaria |
4.2% |
| Abdominal Pain Upper |
2.1% |
| Acute Myocardial Infarction |
2.1% |
| Arthralgia |
2.1% |
|
| Secondary |
| Demyelinating Polyneuropathy |
28.5% |
| Off Label Use |
20.9% |
| Congenital Hypogammaglobulinaemia |
11.7% |
| Primary Immunodeficiency Syndrome |
11.1% |
| Premedication |
6.0% |
| Product Used For Unknown Indication |
6.0% |
| Drug Use For Unknown Indication |
4.3% |
| Immunodeficiency Common Variable |
3.8% |
| Renal Transplant |
1.6% |
| Prophylaxis Against Transplant Rejection |
1.4% |
| Chronic Lymphocytic Leukaemia |
0.8% |
| Dermatomyositis |
0.8% |
| Anaesthesia |
0.5% |
| Guillain-barre Syndrome |
0.5% |
| Hypogammaglobulinaemia |
0.5% |
| Mononeuropathy Multiplex |
0.5% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
0.3% |
| Chronic Sinusitis |
0.3% |
| Depression |
0.3% |
| Epidermolysis Bullosa |
0.3% |
|
| Hepatitis B |
37.6% |
| Deep Vein Thrombosis |
24.7% |
| Drug Intolerance |
5.9% |
| Hepatitis Infectious |
3.5% |
| Wheezing |
3.5% |
| Blood Pressure Increased |
2.4% |
| Infusion Related Reaction |
2.4% |
| Meningitis Aseptic |
2.4% |
| Myocardial Ischaemia |
2.4% |
| Renal Failure Acute |
2.4% |
| Vomiting |
2.4% |
| Cerebrovascular Accident |
1.2% |
| Chest Pain |
1.2% |
| Chills |
1.2% |
| Cytomegalovirus Infection |
1.2% |
| Dizziness |
1.2% |
| Dyspnoea |
1.2% |
| Febrile Neutropenia |
1.2% |
| Feeling Hot |
1.2% |
| Haemolytic Anaemia |
1.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
74.7% |
| Immunodeficiency Common Variable |
5.3% |
| Mycosis Fungoides |
4.0% |
| Chronic Lymphocytic Leukaemia |
2.7% |
| Prophylaxis |
2.7% |
| Thrombocytopenia |
2.7% |
| Chronic Inflammatory Demyelinating Polyradiculoneuropathy |
1.3% |
| Convulsion Prophylaxis |
1.3% |
| Demyelinating Polyneuropathy |
1.3% |
| Immunodeficiency Congenital |
1.3% |
| Multiple Myeloma |
1.3% |
| Rash |
1.3% |
|
| Drug Level Increased |
23.1% |
| Headache |
15.4% |
| Urticaria |
15.4% |
| Myasthenia Gravis |
7.7% |
| Pneumonia |
7.7% |
| Productive Cough |
7.7% |
| Sepsis |
7.7% |
| Status Epilepticus |
7.7% |
| Thrombocythaemia |
7.7% |
|
